Anika Therapeutics, Inc. Finance Lease, Liability, to be Paid, after Year Five
Anika Therapeutics, Inc. (ANIK) had Finance Lease, Liability, to be Paid, after Year Five of $0 as of 2021-12-31, per its 10-K filed 2022-03-11.
Discontinued › Notes › Commitment and Contingencies › Finance Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive · last filed 2022-03-11
- 2021-12-31: Finance Lease, Liability, to be Paid, after Year Five $0.00.
- 2020-12-31: Finance Lease, Liability, to be Paid, after Year Five $0.00.
- 2020-09-30: Finance Lease, Liability, to be Paid, after Year Five $0.00.
| Period end | Finance Lease, Liability, to be Paid, after Year Five |
|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-03-11 |
| 2020-12-31 | $0.00 10-K/A · filed 2021-04-26 |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |